We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$4.35B
AUM Growth
-$166M
Cap. Flow
-$40.7M
Cap. Flow %
-0.94%
Top 10 Hldgs %
29.99%
Holding
855
New
111
Increased
222
Reduced
267
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 20.66%
2 Financials 7.46%
3 Healthcare 7.26%
4 Communication Services 6%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLN icon
701
Haleon
HLN
$43.7B
$210K ﹤0.01%
20,979
-280
-1% -$2.91K
AEE icon
702
Ameren
AEE
$30.4B
$209K ﹤0.01%
+1,903
New +$203K
KBH icon
703
KB Home
KBH
$3.38B
$207K ﹤0.01%
+4,000
New +$235K
RGR icon
704
Sturm, Ruger & Co
RGR
$618M
$204K ﹤0.01%
+5,100
New +$194K
SUI icon
705
Sun Communities
SUI
$14.7B
$202K ﹤0.01%
+1,600
New +$207K
TOL icon
706
Toll Brothers
TOL
$13.8B
$200K ﹤0.01%
+1,466
New +$215K
ESCA icon
707
Escalade
ESCA
$265M
$196K ﹤0.01%
+11,430
New +$173K
PESI icon
708
Perma-Fix Environmental Services
PESI
$353M
$190K ﹤0.01%
17,800
GLRE icon
709
Greenlight Captial
GLRE
$547M
$180K ﹤0.01%
+10,400
New +$151K
TALO icon
710
Talos Energy
TALO
$2.47B
$161K ﹤0.01%
+10,200
New +$131K
LCUT icon
711
Lifetime Brands
LCUT
$194M
$155K ﹤0.01%
+27,089
New +$103K
ZVRA icon
712
Zevra Therapeutics
ZVRA
$736M
$137K ﹤0.01%
14,700
+1,800
+14% +$16.2K
GO icon
713
Grocery Outlet
GO
$919M
$136K ﹤0.01%
19,289
NKTX icon
714
Nkarta
NKTX
$185M
$134K ﹤0.01%
63,400
ARTV
715
Artiva Biotherapeutics
ARTV
$486M
$133K ﹤0.01%
+20,700
New +$102K
ZDGE icon
716
Zedge
ZDGE
$39.3M
$131K ﹤0.01%
44,785
-15,315
-25% -$49.5K
CRBP icon
717
Corbus Pharmaceuticals
CRBP
$166M
$127K ﹤0.01%
+13,500
New +$114K
SLP icon
718
Simulations Plus
SLP
$369M
$118K ﹤0.01%
+10,000
New +$147K
VNDA icon
719
Vanda Pharmaceuticals
VNDA
$330M
$116K ﹤0.01%
+16,800
New +$130K
NUVB icon
720
Nuvation Bio
NUVB
$2.24B
$116K ﹤0.01%
+27,000
New +$150K
PBYI icon
721
Puma Biotechnology
PBYI
$437M
$116K ﹤0.01%
+18,100
New +$117K
EBS icon
722
Emergent Biosolutions
EBS
$395M
$113K ﹤0.01%
+13,600
New +$141K
ORMP icon
723
Oramed Pharmaceuticals
ORMP
$165M
$110K ﹤0.01%
+32,478
New +$110K
BDTX icon
724
Black Diamond Therapeutics
BDTX
$107M
$110K ﹤0.01%
+51,500
New +$122K
WHWK
725
Whitehawk Therapeutics
WHWK
$193M
$108K ﹤0.01%
+31,398
New +$98.3K

Similar funds

Bailard's Q1 2026 Portfolio in Review

As of Q1 2026, Bailard held 855 positions worth $4.35B, down 3.7% from $4.52B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bailard's Q1 2026 filing shows 111 new, 222 increased, 267 reduced and 119 closed positions. Its largest new stake was iShares iBonds Dec 2028 Term Treasury ETF: 1,361,953 shares worth $30.3M. The largest sale was Invesco QQQ Trust, an estimated $92.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Bailard's largest Q1 2026 buy was iShares iBonds Dec 2028 Term Treasury ETF: 1,361,953 shares worth $30.3M.
  • Bailard added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2026, an estimated $87.1M increase.
  • Bailard's biggest Q1 2026 reduction was Invesco QQQ Trust, cutting an estimated $92.5M.
  • Bailard fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q1 2026, selling an estimated $26.6M.
  • Bailard's ten largest holdings make up 30% of its $4.35B portfolio in Q1 2026.
  • Bailard opened 111 new positions and closed 119 in Q1 2026.
  • Bailard's portfolio value fell 3.7% quarter-over-quarter to $4.35B.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.